$ICE

Hague William Jefferson sold $186K of ICE

Hague William Jefferson sold 1,333 shares of Intercontinental Exchange, Inc. (ICE) at $139.46 ($0.19M total) on 2026-06-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Hague William Jefferson
Published Jun 16, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 16, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ICE
Neutral
high confidence
Mentioned
$ICE
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ICENeutralLow
01

Why it matters

A director’s open-market sale under a pre-arranged 10b5-1 plan is generally not a fundamental catalyst, but it updates the insider activity record.

02

Market read

Primarily relevant for monitoring insider activity; unlikely to drive a sustained repricing by itself.

03

What to watch

The article provides only the sale size and plan type; it does not indicate whether there were offsetting buys, option exercises, or broader insider activity around the same period.

Relevance 3/10Novelty 6/10Timing: filed 2026-06-16 (Form 4) for a 2026-06-12 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Intercontinental Exchange, Inc.

Company-level read

Ticker impact

$ICENeutralHigh confidence
Context

Intercontinental Exchange director Hague William Jefferson sold 1,333 shares at $139.46 under a pre-arranged 10b5-1 plan, totaling about $185.9K.

Expected impact

Low near-term impact; any effect is likely noise unless paired with other disclosures.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated pre-arranged 10b5-1 plan and modest dollar value relative to the company.

Market effects

No sector read-through; this is a single-company insider liquidity disclosure.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with private risk perceptions; traders may still monitor for clustering with other negative disclosures.

Key entities

  • Intercontinental Exchange, Inc.

    ICE disclosed a director Form 4 sale of 1,333 shares at $139.46 on 10b5-1.

  • Hague William Jefferson

    Director who sold shares; filing reports holdings after the transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MKTXHighAI 9/10

MarketAxess Holdings Inc. entered into an Agreement and Plan of Merger with Intercontinental Exchange, Inc. and Igloo Merger Sub II, Inc., providing for the…

MARKETAXESS HOLDINGS INC (MKTX) filed an SEC Form 8-K — Other Events. Item 8.01. Other Events. As previously disclosed, on July 29, 2026, MarketAxess Holdings Inc. (“ MarketAxess ”) entered into an Agreement and Plan of Merger with Intercontinental Exchange, Inc. (“ Parent ”) and Igloo Merger Sub II, Inc. (“ Merger Sub ”), providing for the merger

$ICEMed

NYSE Owner Challenges CME in Livestock Futures Market

Intercontinental Exchange (NYSE owner) plans to launch cattle and hog futures contracts by December 7, pending approval, challenging CME Group. It will offer physically settled cattle futures and three cash-settled contracts. CME is updating its trading infrastructure, with some traders concerned about costs and speeds.

$ICEMed

ICE to launch cattle and hog futures in challenge to CME

Intercontinental Exchange (ICE) plans to launch cattle and hog futures contracts on December 7, pending regulatory approval. ICE aims to compete with CME Group, offering physically delivered US live cattle futures and financially settled futures for live cattle, feeder cattle, and lean hogs. CME recently canceled plans to temporarily relocate livestock markets to Dallas, citing faster progress on cloud migration.

$ICEMed

Intercontinental Exchange stock price target maintained at $170 by KBW

Keefe Bruyette & Woods maintained an Outperform rating and $170 price target for Intercontinental Exchange (NYSE: ICE), citing strong long-term energy outlook and data center growth. ICE reported Q2 adjusted EPS of $1.90, revenue of $2.67B, and record recurring revenue of $1.4B. The company announced a $5.7B deal to acquire MarketAxess Holdings and introduced precious metals futures in London.